saclofen has been researched along with carbamazepine in 1 studies
| Studies (saclofen) | Trials (saclofen) | Recent Studies (post-2010) (saclofen) | Studies (carbamazepine) | Trials (carbamazepine) | Recent Studies (post-2010) (carbamazepine) |
|---|---|---|---|---|---|
| 107 | 0 | 20 | 11,992 | 1,128 | 3,101 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, G; Ebner, TJ; Gao, W; Hendrix, CM; Popa, LS; Reinert, KC; Ross, ME | 1 |
1 other study(ies) available for saclofen and carbamazepine
| Article | Year |
|---|---|
Involvement of kv1 potassium channels in spreading acidification and depression in the cerebellar cortex.
Topics: Acetazolamide; Acids; Animals; Anticonvulsants; Baclofen; Bicuculline; Carbamazepine; Cerebral Cortex; Cortical Spreading Depression; Cyclin D2; Cyclins; Diagnostic Imaging; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Drug Interactions; Electric Stimulation; Female; GABA Antagonists; Glutamic Acid; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Neutral Red; Peptides; Potassium Channel Blockers; Potassium Channels; Reaction Time; Scorpion Venoms; Shaker Superfamily of Potassium Channels; Time Factors | 2005 |